The validity of predicting prognosis by the number of lymph node metastases in node-positive colon cancer

Kiichi Sugimoto, Masaya Kawai, Kazuhiro Takehara, Yoshihiko Tashiro, Shinya Munakata, Kiichi Nagayasu, Koichiro Niwa, Shun Ishiyama, Hiromitsu Komiyama, Makoto Takahashi, Yutaka Kojima, Michitoshi Goto (+2 others)
2013 Open Journal of Gastroenterology  
We examined the possibility of predicting prognosis by the number of lymph node metastases. Methods: Two hundred and forty-nine patients with lymph node metastases who underwent curative surgery for colon cancer were enrolled in this study. We calculated cancer-specific survival according to the number of lymph node metastases. Results: There was a tendency toward better rates of cancer-specific survivals among the patients with 1 LNM, compared with those with 2 LNM (p = 0.07). When comparing
more » ... ). When comparing cancer-specific survival between the patients with 1, 2 -3 and 4 or more lymph node metastases, cancerspecific survival was well stratified (p < 0.0001). With regard to stage classification, in the Japanese classification, there was a significant difference in cancerspecific survival between Stages IIIa and IIIb (p < 0.0001). On the other hand, in the TNM classification, cancer-specific survivals in Stages IIIA, IIIB and IIIC were stratified into three groups with significant differences (IIIA vs. IIIB; p = 0.007, IIIB vs. IIIC; p < 0.0001). Conclusion: It appeared to be valid to stratify cancer-specific survival into three groups, i.e., the patients with 1, 2 and 3 and 4 or more lymph node metastases. This study was in favor of the TNM classification in which N category is classified by the number of lymph node metastases.
doi:10.4236/ojgas.2013.34036 fatcat:4tfkanqgx5auhas6abgtfb743m